Evidence map›Paper›PMID 38127423›Full record

ArticleeLife2023

CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment.

Musleh M Muthana, Xuexiang Du, Mingyue Liu, Xu Wang, Wei Wu, Chunxia Ai, Lishan Su, Pan Zheng, Yang Liu

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. B cells in cancer: functions, mechanisms and therapeutic advances.Signal transduction and targeted therapy · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Musleh M MuthanaDivision of Immunotherapy, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, United States.ORCID 0000-0003-1242-5631
Xuexiang DuKey Laboratory of Infection and Immunity of Shandong Province & Department of Immunology, School of Basic Medical Sciences, Shandong University, Jinan, China.
Mingyue LiuDivision of Immunotherapy, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, United States.
Xu WangDivision of Immunotherapy, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, United States.
Wei WuOncoC4, Inc, Rockville, United States.
Chunxia AiKey Laboratory of Infection and Immunity of Shandong Province & Department of Immunology, School of Basic Medical Sciences, Shandong University, Jinan, China.
Lishan SuDivision of Immunotherapy, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, United States.
Pan ZhengOncoC4, Inc, Rockville, United States.
Yang LiuOncoC4, Inc, Rockville, United States.
University of Maryland, Baltimore · US

Funding

Modeling immune impairments and pathogenesis in novel humanized mice for HBV-HIV co-infectionR01AI138797 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PLOSS, ALEXANDER, SU, LISHAN · 2018 to 2022
$3.9M
Preserving CTLA-4 immune checkpoint for safer and more effective cancer immunotherapyR01AI154722 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI SU, LISHAN · 2020 to 2024
$2.6M
Immune Mechanisms of Elevated Liver Diseases During HIV InfectionR01DK119937 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SU, LISHAN · 2018 to 2022
$1.9M
NIAID NIH HHS R01 AI138797NIAID NIH HHS R01 AI154722NIDDK NIH HHS R01 DK119937NIH HHS R01AI154722
6 · The paper itself

Abstract

Germline CTLA-4 deficiency causes severe autoimmune diseases characterized by dysregulation of Foxp3

Indexed as

AbataceptB-LymphocytesT-Lymphocytes, RegulatoryAnimalsApoptosisCHO CellsCricetulusCTLA-4 AntigenFemaleImmunoglobulinsLymphocyte DepletionMaleMiceMice, Inbred C57BLAbataceptCTLA-4 AntigenImmunoglobulinsADCB cell lossCTLA-4Foxp3immunologyinflammationmouseTreg-depletion

Identifiers

PMID38127423
PMCPMC10735222
OpenAlexW4367846030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.